Epstein-Barr virus and tumor promoters

Area of Science:

• Virology
• Molecular Biology
• Cancer Research

Background:

• Epstein-Barr virus (EBV) establishes latent infections in lymphoblastoid cell lines, complicating studies of its lytic cycle.
• A lack of fully permissive cells hinders research into EBV's lytic functions.
• Lymphoblastoid cell lines offer a model for investigating EBV latency and lytic activity.

Purpose of the Study:

• To investigate the lytic functions of Epstein-Barr virus (EBV) in lymphoblastoid cell lines.
• To explore the use of chemical inducers for activating latent EBV and studying viral production.
• To evaluate the potential of this model system for in vitro assays of tumor promoters and their mechanisms.

Main Methods:

• Induction of EBV replication in lymphoblastoid cell lines using phorbol esters, n-butyrate, or nucleotide analogues.
• Analysis of latent and lytic functions of EBV under induced conditions.
• Investigation of the mechanisms underlying tumor promoter and n-butyrate-induced EBV activation.

Main Results:

• Virus production from latent EBV infections can be reliably induced in lymphoblastoid cell lines.
• Specific chemical compounds effectively trigger the lytic cycle of EBV.
• The model system demonstrates utility in studying EBV's molecular mechanisms and responses to potential tumor promoters.

Conclusions:

• Lymphoblastoid cell lines provide a valuable platform for studying EBV lytic functions.
• Chemical induction offers a method to investigate EBV's life cycle and interactions with cellular processes.
• This system aids in understanding EBV-associated oncogenesis and the effects of tumor promoters.